Grandview Asset Management LLC Gilead Sciences, Inc. Transaction History

Grandview Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$63.47 - $69.35 $19,421 - $21,221	-306 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$60.0 - $68.46 $12,240 - $13,965	204 Added 200.0%	306 $20,000
Q1 2021 May 06, 2021	BUY	$60.0 - $68.46 $6,120 - $6,982	102 New	102 $24,000
Q4 2020 Jan 21, 2021	SELL	$56.65 - $64.55 $640,145 - $729,415	-11,300 Closed	0 $0
Q3 2020 Oct 30, 2020	SELL	$62.1 - $78.08 $242,190 - $304,512	-3,900 Reduced 25.66%	11,300 $714,000
Q2 2020 Jul 23, 2020	BUY	$72.34 - $84.0 $1.1 Million - $1.28 Million	15,200 New	15,200 $1.17 Million

1,904

1.02B

12M

9.02M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Grandview Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Grandview Asset Management LLC with notifications on news.